2023. 11. 21
New C2H Report: Valbenazine (Dysval)
2023. 11. 04
New C2H Report: Bimekizumab (Bimzelx)
2023. 10. 29
New C2H Report: Andexanet alfa (Ondexxya)
View all news
2019. 03. 06
International symposium - Current status and future role of HTA in Japan and other countries
View all events
View all reports